Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Springtide Ventures
Deal Size : $9.3 million
Deal Type : Financing
Leash Announces $9.3 Million Seed Financing to Pioneer AI-Driven Medicinal Chemistry
Details : The net proceeds will support development of a foundational machine learning model of medicinal chemistry that can accurately predict small molecule drug candidates for any protein.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 04, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Springtide Ventures
Deal Size : $9.3 million
Deal Type : Financing
Reset All
